ResMed Inc.

RMD

Find Out if You Qualify for a Financial Reward by filling out the form below.

ResMed Inc. Form












Stock Fraud Law Center does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

On August 3, 2023, ResMed reported results for the fourth quarter of fiscal 2023. Analysts lowered their ratings in response to ResMed’s report, citing concerns over market share and gross margins. Following ResMed’s announcements, on August 4, 2023, ResMed’s stock price fell from $219.95 per share to $179.25 per share, a decline of more than $40 per share.

Active Cases

Ticker Symbol Company Name Join Deadline Join
AGEN Agenus Inc. November 05, 2024 Join
NFE New Fortress Energy Inc. November 18, 2024 Join
MGX Metagenomi, Inc. November 25, 2024 Join
BMBL Bumble Inc. November 25, 2024 Join
UPS United Parcel Service, Inc. December 09, 2024 Join
EW Edwards Lifesciences Corporation December 13, 2024 Join
TD The Toronto-Dominion Bank December 23, 2024 Join